Literature DB >> 28376173

Shared Gene Expression Alterations in Nasal and Bronchial Epithelium for Lung Cancer Detection.

.   

Abstract

Background: We previously derived and validated a bronchial epithelial gene expression biomarker to detect lung cancer in current and former smokers. Given that bronchial and nasal epithelial gene expression are similarly altered by cigarette smoke exposure, we sought to determine if cancer-associated gene expression might also be detectable in the more readily accessible nasal epithelium.
Methods: Nasal epithelial brushings were prospectively collected from current and former smokers undergoing diagnostic evaluation for pulmonary lesions suspicious for lung cancer in the AEGIS-1 (n = 375) and AEGIS-2 (n = 130) clinical trials and gene expression profiled using microarrays. All statistical tests were two-sided.
Results: We identified 535 genes that were differentially expressed in the nasal epithelium of AEGIS-1 patients diagnosed with lung cancer vs those with benign disease after one year of follow-up ( P  < .001). Using bronchial gene expression data from the AEGIS-1 patients, we found statistically significant concordant cancer-associated gene expression alterations between the two airway sites ( P  < .001). Differentially expressed genes in the nose were enriched for genes associated with the regulation of apoptosis and immune system signaling. A nasal lung cancer classifier derived in the AEGIS-1 cohort that combined clinical factors (age, smoking status, time since quit, mass size) and nasal gene expression (30 genes) had statistically significantly higher area under the curve (0.81; 95% confidence interval [CI] = 0.74 to 0.89, P  = .01) and sensitivity (0.91; 95% CI = 0.81 to 0.97, P  = .03) than a clinical-factor only model in independent samples from the AEGIS-2 cohort. Conclusions: These results support that the airway epithelial field of lung cancer-associated injury in ever smokers extends to the nose and demonstrates the potential of using nasal gene expression as a noninvasive biomarker for lung cancer detection.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28376173      PMCID: PMC6059169          DOI: 10.1093/jnci/djw327

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  32 in total

1.  Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.

Authors:  M Adachi; T Taki; Y Ieki; C L Huang; M Higashiyama; M Miyake
Journal:  Cancer Res       Date:  1996-04-15       Impact factor: 12.701

2.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

3.  Pattern of antioxidant and DNA repair gene expression in normal airway epithelium associated with lung cancer diagnosis.

Authors:  Thomas Blomquist; Erin L Crawford; D'Anna Mullins; Youngsook Yoon; Dawn-Alita Hernandez; Sadik Khuder; Patricia L Ruppel; Elizabeth Peters; David J Oldfield; Brad Austermiller; John C Anders; James C Willey
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

4.  A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment.

Authors:  Katrina Steiling; Maarten van den Berge; Kahkeshan Hijazi; Roberta Florido; Joshua Campbell; Gang Liu; Ji Xiao; Xiaohui Zhang; Grant Duclos; Eduard Drizik; Huiqing Si; Catalina Perdomo; Charles Dumont; Harvey O Coxson; Yuriy O Alekseyev; Don Sin; Peter Pare; James C Hogg; Annette McWilliams; Pieter S Hiemstra; Peter J Sterk; Wim Timens; Jeffrey T Chang; Paola Sebastiani; George T O'Connor; Andrea H Bild; Dirkje S Postma; Stephen Lam; Avrum Spira; Marc E Lenburg
Journal:  Am J Respir Crit Care Med       Date:  2013-05-01       Impact factor: 21.405

5.  Diagnostic Yield and Complications of Bronchoscopy for Peripheral Lung Lesions. Results of the AQuIRE Registry.

Authors:  David E Ost; Armin Ernst; Xiudong Lei; Kevin L Kovitz; Sadia Benzaquen; Javier Diaz-Mendoza; Sara Greenhill; Jennifer Toth; David Feller-Kopman; Jonathan Puchalski; Daniel Baram; Raj Karunakara; Carlos A Jimenez; Joshua J Filner; Rodolfo C Morice; George A Eapen; Gaetane C Michaud; Rosa M Estrada-Y-Martin; Samaan Rafeq; Horiana B Grosu; Cynthia Ray; Christopher R Gilbert; Lonny B Yarmus; Michael Simoff
Journal:  Am J Respir Crit Care Med       Date:  2016-01-01       Impact factor: 21.405

6.  A prediction model for lung cancer diagnosis that integrates genomic and clinical features.

Authors:  Jennifer Beane; Paola Sebastiani; Theodore H Whitfield; Katrina Steiling; Yves-Martine Dumas; Marc E Lenburg; Avrum Spira
Journal:  Cancer Prev Res (Phila)       Date:  2008-03-31

7.  Down-regulation of miR-150 induces cell proliferation inhibition and apoptosis in non-small-cell lung cancer by targeting BAK1 in vitro.

Authors:  Xiao-yan Gu; Jun Wang; Yi-zhou Luo; Qiang Du; Ruo-ran Li; Hui Shi; Tian-pei Yu
Journal:  Tumour Biol       Date:  2014-02-16

8.  ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation.

Authors:  Yanfang Wang; Rajamani Rathinam; Amelia Walch; Suresh K Alahari
Journal:  J Biol Chem       Date:  2009-06-22       Impact factor: 5.157

9.  Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy.

Authors:  Duncan H Whitney; Michael R Elashoff; Kate Porta-Smith; Adam C Gower; Anil Vachani; J Scott Ferguson; Gerard A Silvestri; Jerome S Brody; Marc E Lenburg; Avrum Spira
Journal:  BMC Med Genomics       Date:  2015-05-06       Impact factor: 3.063

10.  Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study.

Authors:  Nichole T Tanner; Jyoti Aggarwal; Michael K Gould; Paul Kearney; Gregory Diette; Anil Vachani; Kenneth C Fang; Gerard A Silvestri
Journal:  Chest       Date:  2015-12       Impact factor: 9.410

View more
  15 in total

1.  Lung Cancer Field Cancerization: Implications for Screening by Low-Dose Computed Tomography.

Authors:  Ana I Robles; Curtis C Harris
Journal:  J Natl Cancer Inst       Date:  2017-07-01       Impact factor: 13.506

Review 2.  Genomic approaches to accelerate cancer interception.

Authors:  Jennifer Beane; Joshua D Campbell; Julian Lel; Jessica Vick; Avrum Spira
Journal:  Lancet Oncol       Date:  2017-07-26       Impact factor: 41.316

Review 3.  Lung cancer health disparities.

Authors:  Bríd M Ryan
Journal:  Carcinogenesis       Date:  2018-05-28       Impact factor: 4.944

4.  Comparative mechanisms of PAH toxicity by benzo[a]pyrene and dibenzo[def,p]chrysene in primary human bronchial epithelial cells cultured at air-liquid interface.

Authors:  Yvonne Chang; Lisbeth K Siddens; Lauren K Heine; David A Sampson; Zhen Yu; Kay A Fischer; Christiane V Löhr; Susan C Tilton
Journal:  Toxicol Appl Pharmacol       Date:  2019-06-27       Impact factor: 4.219

5.  Clinical Study of Aspirin and Zileuton on Biomarkers of Tobacco-Related Carcinogenesis in Current Smokers.

Authors:  Linda L Garland; José Guillen-Rodriguez; Chiu-Hsieh Hsu; Lisa E Davis; Eva Szabo; Christopher R Husted; Hanqiao Liu; Ashley LeClerc; Yuriy O Alekseyev; Gang Liu; Julie E Bauman; Avrum E Spira; Jennifer Beane; Malgorzata Wojtowicz; H-H Sherry Chow
Journal:  Cancers (Basel)       Date:  2022-06-11       Impact factor: 6.575

6.  In vitro RNA-seq-based toxicogenomics assessment shows reduced biological effect of tobacco heating products when compared to cigarette smoke.

Authors:  Linsey E Haswell; Sarah Corke; Ivan Verrastro; Andrew Baxter; Anisha Banerjee; Jason Adamson; Tomasz Jaunky; Christopher Proctor; Marianna Gaça; Emmanuel Minet
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

Review 7.  Smoking and Lung Cancer: A Geo-Regional Perspective.

Authors:  Zahraa Rahal; Shaza El Nemr; Ansam Sinjab; Hassan Chami; Arafat Tfayli; Humam Kadara
Journal:  Front Oncol       Date:  2017-09-01       Impact factor: 6.244

8.  Inflammatory pathways are upregulated in the nasal epithelium in patients with idiopathic pulmonary fibrosis.

Authors:  Marc A Sala; Yalbi Itzel Balderas-Martínez; Ivette Buendía-Roldan; Hiam Abdala-Valencia; Kiwon Nam; Manu Jain; Sangeeta Bhorade; Ankit Bharat; Paul A Reyfman; Karen M Ridge; Annie Pardo; Jacob I Sznajder; G R Scott Budinger; Alexander V Misharin; Moises Selman
Journal:  Respir Res       Date:  2018-11-26

9.  POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer.

Authors:  Zhen Wu; Yue-Ming Wang; Yu Dai; Liang-An Chen
Journal:  Med Sci Monit       Date:  2020-04-18

10.  Smoking Status at Diagnosis and Colorectal Cancer Prognosis According to Tumor Lymphocytic Reaction.

Authors:  Kenji Fujiyoshi; Yang Chen; Koichiro Haruki; Tomotaka Ugai; Junko Kishikawa; Tsuyoshi Hamada; Li Liu; Kota Arima; Jennifer Borowsky; Juha P Väyrynen; Melissa Zhao; Mai Chan Lau; Simeng Gu; Shanshan Shi; Naohiko Akimoto; Tyler S Twombly; David A Drew; Mingyang Song; Andrew T Chan; Edward L Giovannucci; Jeffrey A Meyerhardt; Charles S Fuchs; Reiko Nishihara; Jochen K Lennerz; Marios Giannakis; Jonathan A Nowak; Xuehong Zhang; Kana Wu; Shuji Ogino
Journal:  JNCI Cancer Spectr       Date:  2020-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.